Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMOC Group Limited, formerly known as China Molybdenum Co., Ltd., is a leading global mining company specializing in the extraction, processing, and trading of base and rare metals. Headquartered in Luoyang, China, the company is one of the world's largest producers of molybdenum, tungsten, cobalt, and niobium, and a significant producer of copper. While not a biotechnology or pharmaceutical company, CMOC is a critical supplier to the life sciences industry as the world's second-largest producer of cobalt, a key component in the production of Vitamin B12 and medical alloys. The company operates a global portfolio of high-quality assets across Asia, Africa, South America, and Oceania, and owns IXM, one of the world's largest base metals merchants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMOC.